聚桂醇硬化剂联合长脉冲1064nm Nd:YAG激光治疗婴幼儿混合型血管瘤的临床分析  

Clinical analysis of Lauromacrogol Hardener Combined with long pulse 1064nm Nd:YAG laster to treat Infantile Mixed Hemangioma

作　　者：封志强[1] 付燕 徐伟立[3] FENG Zhiqiang;FU Yan;XU Weili(Third Department of surgrry,Tai’an Maternal and Child Care Hospital,Tai’an Shandong 271000,China;The second affiliated hospital of shandong first medical university,Tai’an Shandong 271000,China;Department of pediatric surgery,the second hospital of hebei medical university,Shijiazhuang Hebei 050000,China)

机构地区：[1]泰安市妇幼保健院外三科,山东泰安271000 [2]山东第一医科大学第二附属医院儿科,山东泰安271000 [3]河北医科大学第二医院小儿外科,河北石家庄050000

出　　处：《临床研究》2020年第6期35-36,共2页Clinical Research

摘　　要：目的探究婴幼儿混合型血管瘤采用聚桂醇硬化剂与长脉冲1064nm Nd:YAG激光联合治疗的临床疗效。方法纳入90例2017年10月-2018年9月本院收治的混合型血管瘤婴幼儿开展研究,按随机排列法分为对照组45例,进行单独长脉冲1064nm Nd:YAG激光治疗;研究组45例,在对照组治疗基础上加用聚桂醇硬化剂治疗,观察临床疗效。结果研究组临床有效率为88.89%,高于对照组77.78%(P<0.05);患儿年龄、瘤体大小对疗效的影响差异有统计学意义(P<0.05)。结论婴幼儿混合型血管瘤采用聚桂醇硬化剂与长脉冲1064nm Nd:YAG激光联合治疗可取得较好的效果,早期积极治疗可促进预后。Objective:To investigate the clinical efficacy of lauromacrogol hardener combined with long pulse 1064 nm Nd:YAG laster to treat infantile mixed hemangioma.Methods:90 cases of mixed hemangioma infants admitted to our hospital were included in the study,and 45 cases were randomLy divided into the control group for single long pulse 1064 nm Nd:YAG laser treatment.45 cases were treated with lauromacrogol sclerotherapy.Results:The clinical effective rate of the study group was 88.89%,higher than that of the control group 77.78%(P<0.05).The effect of age and tumor size on the curative effect of children was statistically significant(P<0.05).Conclusion:Combined treatment with lauromacrogol sclerotherapy and long pulse 1064 nm Nd:YAG laser can achieve good results,and early active treatment can promote the prognosis of infantile mixed hemangioma.

关 键 词：婴幼儿 混合型血管瘤 长脉冲1064nm Nd:YAG激光 聚桂醇硬化剂 

分 类 号：R732.2[医药卫生—肿瘤]